AI assistant
Sending…
INSMED Inc — Director's Dealing 2016
Feb 3, 2016
30150_dirs_2016-02-03_9f1fd055-d560-4988-b780-2846899b3063.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2016-02-01
Reporting Person: Lewis William (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-02-01 | Common Stock | P | 50000 | $13.34 | Acquired | 96972 | Direct |
Footnotes
F1: Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 17, 2015.
F2: The price in column 4 is a weighted average price. The prices actually paid by the Reporting Person in these transactions range from $12.97 to $13.63.
F3: The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range reported.
More from INSMED Inc
Regulatory Filings
2026
May 15
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Report Publication Announcement
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 7
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 19